NCT02197884View on ClinicalTrials.gov

A Study to Assess Effects of Clarithromycin on Pharmacokinetics of JNJ-54861911 in Healthy Male Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

July 31, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Healthy
Interventions
DRUG

JNJ-54861911, 25 mg

JNJ-54861911, 25 mg tablet orally on Day 1 and Day 9.

DRUG

Itraconazole 200 mg

Itraconazole 200 mg (2\*100 mg capsule) orally once daily from Day 5 to Day 12.

DRUG

Clarithromycin 500 mg

Clarithromycin 500 mg immediate release tablet orally twice daily from Day 5 to Day 12.

Trial Locations (1)

Unknown

Merksem

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY

NCT02197884 - A Study to Assess Effects of Clarithromycin on Pharmacokinetics of JNJ-54861911 in Healthy Male Participants | Biotech Hunter | Biotech Hunter